Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

An Open Letter To The Health Minister From An Outback GP, Australia
An Alice Springs doctor has urged the Federal Government to overhaul Medicare to remove disincentives for General Practitioners to conduct longer consultations with patients.
generic viagra online
Health Chair's Stance On Pet-Free Flights Very Disappointing: Lung Association, Canada
The Canadian Lung Association expressed disappointment in federal Health Committee Chair Joy Smith"s stance on the issue of Air Canada and WestJet"s policy to allow pets to travel in the passenger cabin of airplanes. The Lung Association launched an online campaign for pet-free flights in July following the decision by Air Canada to join WestJet in offering pet-free flights, despite the serious risks it presents to passengers and crew with asthma, COPD and severe animal allergies.
News of the day
Biotechnology Reports Biochemical Findings From Phase IIa Study With Hypertension Vaccine CYT006-AngQb
Cytos Biotechnology Ltd (SIX:CYTN) announced results from a biochemical analysis from a phase IIa study (study 02) with the vaccine
Nutrition

Biomarkers In Cardiovascular Endocrinology: The Endocrine Society's 2009 Corporate Liaison Board Forum

The Endocrine Society"s Corporate Liaison Board (CLB) will host its annual forum on Wednesday June 10, as part of ENDO 09, the Society"s 91th Annual Meeting. The 2009 topic for the forum is "Biomarkers in Cardiovascular Endocrinology in Clinical Trials & Drug Development." The forum includes speakers from industry, academia, and government engaged in multi-perspective discussion on biomarkers in cardiovascular endocrinology, specifically as they relate to clinical trials and drug development. Issues to be discussed by forum participants include: - The Mandate for Development of Biomarkers of Atherosclerotic Cardiovascular Disease: Future Implications David A. Fryburg, MD-- Pfizer, Inc. - Novel Cardiovascular Biomarkers: Experience with Lp-PLA2 Joseph P. McConnell, PhD-- Mayo Clinic - Biomarkers in Cardiovascular Endocrinology in Clinical Trials and Drug Development: Regulatory Perspective Mary H. Parks, MD-- US Food and Drug Administration "This yearly forum provides an excellent opportunity for all perspectives to join together to discuss critical health issues-from the laboratory to drug development through the regulatory process," said Society Program Director, Sethu K. Reddy, MD, MBA. "We encourage a thoughtful interchange between panelists and forum attendees." The CLB serves as an opportunity for regular and direct communication between the Society, The Hormone Foundation, and the pharmaceutical and biotechnology industry in endocrinology. The 2009 forum will be held at the Renaissance Washington DC Hotel in the Grand Ballroom. The session begins at 6:30 p.m. (ET). Reporters may register by contacting Arlyn G. Riskind at (202) 431-9495; ariskind@endo-society.org. The Endocrine Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009